Can I Get a Michigan Medical Marijuana Card for Inflammatory Bowel Disease (IBD / Crohn's)?
Crohn's disease, ulcerative colitis, and related inflammatory bowel conditions.
Yes — inflammatory bowel disease (ibd / crohn's) qualifies under the Michigan Medical Marihuana Program
Inflammatory bowel disease — including Crohn's disease and ulcerative colitis — is a qualifying condition under the Michigan Medical Marihuana Program. Patients with chronic abdominal pain, appetite loss, and inflammatory flares may benefit from medical cannabis as part of their treatment plan.
Common symptoms
- Abdominal pain and cramping
- Chronic diarrhea
- Weight loss
- Reduced appetite
- Joint pain
How medical cannabis may help
Cannabinoids modulate inflammation and gastrointestinal motility through CB1 and CB2 receptors. Patients commonly report reduced abdominal pain, improved appetite, and reduced nausea. Cannabis is considered an adjunct to standard IBD therapy, not a replacement.
Evidence base
A 2013 Israeli randomized controlled trial (Naftali et al., Clinical Gastroenterology and Hepatology) reported that 10 of 11 patients (90%) treated with inhaled cannabis achieved a clinical response — defined as a reduction of more than 100 points in Crohn's Disease Activity Index — compared to 4 of 10 patients (40%) on placebo. Other studies have demonstrated improved quality of life and reduced disease activity scores.
Michigan certification requirements
Documentation of your IBD diagnosis (gastroenterology notes, endoscopy reports) is helpful.
Frequently Asked Questions
- Can medical marijuana replace my biologics or immunosuppressants?
- No. Cannabis is an adjunct to disease-modifying IBD therapy, not a replacement. Continue working with your gastroenterologist.